People
Oculis S.A., a clinical-stage biopharmaceutical company whose mission is to develop novel topical treatments for ophthalmic diseases, announced the appointment of Marcia de Souza Lima, M.D., M.I.P.P., as Chief Medical Officer.
Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, announces the following changes to its Officers and Board of Directors.
Ghosh succeeds current Unity CEO Keith Leonard, who will step down from his role. Leonard will continue as the chairman of the board of directors.
In addition, the company’s chief scientific officer, Seth Ettenberg, has resigned.
Qiagen manufactures diagnostic tests for a variety of diseases including cancer and, currently, the coronavirus that causes COVID-19.
Artificial intelligence and machine learning are increasingly becoming a part of drug discovery and development beginning with identifying new compounds to structuring and designing clinical trials and targeting clinical trial populations.
Scangos, who currently helms Vir Biotechnology, is expected to coordinate the industry’s response to the increasing coronavirus threat.
“This agreement builds on Gilead’s presence in immuno-oncology and adds significant potential to our clinical pipeline,” said Daniel O’Day, Gilead’s chairman and chief executive officer.
Co-founder of Brisbane-based gut analysis company Microba, Professor Gene Tyson, will head up a new field of microbiome-focused research at the Queensland University of Technology.
The company expects to decrease its operating expenses by about 40% this year compared to 2019.
PRESS RELEASES